BRAIN Biotech AG: Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01)

DGAP-News: BRAIN Biotech AG / Key word(s): Miscellaneous/Patent08.12.2021 / 15:00 The issuer is solely responsible for the content of this announcement.Zwingenberg, Germany, December 8th, 2021Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01) Successful extension of proprietary genome editing toolbo...

Related Keywords

Germany ,United Kingdom ,Zwingenberg ,Hessen ,Frankfurt ,Brandenburg ,Lukas Linnig ,Michael Schneiders ,Paul Scholz ,Stephanie Konle ,Pr Corporate Communications ,Standard Of The Frankfurt Stock Exchange ,Distribution Services ,Genome Editing Nuclease ,Engineered Cas ,United Nations Global Compact ,Prime Standard ,Frankfurt Stock Exchange ,Investor Relations ,Corporate News ,Regulatory Announcements ,